The oncogenic role of DAAM2 has been confirmed in glioma and hepatocellular carcinoma (Zhu et al., 2017; Fang et al., 2020), but the biological function of DAAM2 in PAAD needs to be further explored. This evidence concerns the gene DAAM2 and central nervous system cancer.